Tenet Healthcare (THC) Stock Forecast, Price Target & Predictions
THC Stock Forecast
Tenet Healthcare stock forecast is as follows: an average price target of $124.87 (represents a -23.11% downside from THC’s last price of $162.41) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.
THC Price Target
The average price target for Tenet Healthcare (THC) is $124.87 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $170.00 to $47.00. This represents a potential -23.11% downside from THC's last price of $162.41.
THC Analyst Ratings
According to 11 Wall Street analysts, Tenet Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for THC stock is 1 'Strong Buy' (9.09%), 10 'Buy' (90.91%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Tenet Healthcare Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 26, 2024 | Ann Hynes | Mizuho Securities | $170.00 | $151.63 | 12.12% | 4.67% |
| Jul 25, 2024 | David MacDonald | Truist Financial | $170.00 | $147.68 | 15.11% | 4.67% |
| Jul 15, 2024 | David MacDonald | Truist Financial | $155.00 | $132.11 | 17.32% | -4.56% |
| Jul 10, 2024 | Andrew Mok | Barclays | $156.00 | $130.97 | 19.11% | -3.95% |
| Jun 28, 2024 | Pito Chickering | Deutsche Bank | $155.00 | $138.30 | 12.08% | -4.56% |
| Jun 10, 2024 | Jamie Perse | Goldman Sachs | $156.00 | $136.40 | 14.37% | -3.95% |
| May 30, 2024 | Pito Chickering | Deutsche Bank | $150.00 | $131.55 | 14.03% | -7.64% |
| May 29, 2024 | Michael Ha | Robert W. Baird | $153.00 | $131.55 | 16.31% | -5.79% |
| May 02, 2024 | Andrew Mok | Barclays | $147.00 | $115.95 | 26.78% | -9.49% |
| May 01, 2024 | Scott Fidel | Stephens | $122.00 | $112.29 | 8.65% | -24.88% |
The latest Tenet Healthcare stock forecast, released on Jul 26, 2024 by Ann Hynes from Mizuho Securities, set a price target of $170.00, which represents a 12.12% increase from the stock price at the time of the forecast ($151.63), and a 4.67% increase from THC last price ($162.41).
Tenet Healthcare Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 5 | 14 |
| Avg Price Target | - | $161.20 | $146.29 |
| Last Closing Price | $162.41 | $162.41 | $162.41 |
| Upside/Downside | -100.00% | -0.75% | -9.93% |
In the current month, the average price target of Tenet Healthcare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Tenet Healthcare's last price of $162.41. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 14, 2024 | Wells Fargo | Buy | Buy | Hold |
| Aug 14, 2024 | UBS | Underperform | Underperform | Hold |
| Jul 30, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| Jul 25, 2024 | UBS | Buy | Buy | Hold |
| Jul 25, 2024 | Truist Financial | Underperform | Underperform | Hold |
| Jul 25, 2024 | Raymond James | Strong Buy | Strong Buy | Hold |
| Jul 25, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
| Jul 25, 2024 | Citigroup | Buy | Buy | Hold |
| Jul 10, 2024 | Barclays | Overweight | Overweight | Hold |
| Jul 02, 2024 | UBS | Buy | Buy | Hold |
Tenet Healthcare's last stock rating was published by Wells Fargo on Aug 14, 2024. The company gave THC a "Buy" rating, the same as its previous rate.
Tenet Healthcare Financial Forecast
Tenet Healthcare Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $5.38B | - | $5.08B | $5.02B | $4.99B | $4.80B | $4.64B | $4.75B | $4.86B | $4.89B | $4.95B | $4.78B | $4.92B | $4.56B | $3.65B | $4.52B | $4.81B | $4.57B |
| Avg Forecast | $5.86B | $5.60B | $5.52B | $5.58B | $5.57B | $5.31B | $5.31B | $5.42B | $5.32B | $5.07B | $4.99B | $5.15B | $5.27B | $5.02B | $4.91B | $4.84B | $4.91B | $4.81B | $4.78B | $4.71B | $4.99B | $4.83B | $4.77B | $4.76B | $4.86B | $4.39B | $3.75B | $4.63B | $4.76B | $4.46B |
| High Forecast | $5.86B | $5.60B | $5.52B | $5.58B | $5.57B | $5.31B | $5.31B | $5.42B | $5.32B | $5.09B | $5.29B | $5.15B | $5.41B | $5.02B | $4.91B | $4.84B | $4.91B | $4.81B | $4.81B | $4.73B | $5.02B | $4.86B | $4.80B | $4.79B | $4.89B | $4.41B | $3.77B | $4.66B | $4.79B | $4.48B |
| Low Forecast | $5.86B | $5.60B | $5.52B | $5.58B | $5.57B | $5.31B | $5.31B | $5.42B | $5.32B | $5.03B | $4.83B | $5.15B | $5.21B | $5.02B | $4.91B | $4.84B | $4.91B | $4.81B | $4.74B | $4.67B | $4.95B | $4.80B | $4.73B | $4.73B | $4.82B | $4.35B | $3.72B | $4.59B | $4.72B | $4.42B |
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 16 | 4 | 7 | 1 | - | - | - | - | - | - | - | - | - | - | - | 9 | 9 | 9 | 13 | 13 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | - | 1.03% | 1.04% | 1.02% | 1.00% | 0.97% | 1.01% | 0.97% | 1.01% | 1.04% | 1.00% | 1.01% | 1.04% | 0.97% | 0.98% | 1.01% | 1.03% |
Tenet Healthcare's average Quarter revenue forecast for Mar 24 based on 4 analysts is $5.15B, with a low forecast of $5.15B, and a high forecast of $5.15B. THC's average Quarter revenue forecast represents a -4.30% decrease compared to the company's last Quarter revenue of $5.38B (Dec 23).
Tenet Healthcare EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 16 | 4 | 7 | 1 | - | - | - | - | - | - | - | - | - | - | - | 9 | 9 | 9 | 13 | 13 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-1.13B | - | $200.00M | $830.00M | $901.00M | $847.00M | $843.00M | $888.00M | $1.01B | $862.00M | $833.00M | $787.00M | $1.30B | $551.00M | $734.00M | $586.00M | $803.00M | $627.00M |
| Avg Forecast | $992.74M | $947.99M | $935.27M | $945.62M | $943.15M | $899.24M | $899.58M | $917.37M | $901.54M | $858.12M | $845.10M | $702.80M | $892.95M | $851.03M | $831.78M | $638.91M | $832.08M | $1.09B | $809.45M | $505.07M | $844.65M | $818.81M | $807.96M | $372.52M | $822.83M | $743.28M | $635.39M | $835.20M | $805.87M | $754.70M |
| High Forecast | $992.74M | $947.99M | $935.27M | $945.62M | $943.15M | $899.24M | $899.58M | $917.37M | $901.54M | $861.52M | $895.88M | $843.36M | $916.72M | $851.03M | $831.78M | $766.69M | $832.08M | $1.31B | $814.25M | $606.08M | $849.67M | $823.67M | $812.76M | $447.02M | $827.71M | $747.70M | $639.16M | $1.00B | $810.65M | $759.18M |
| Low Forecast | $992.74M | $947.99M | $935.27M | $945.62M | $943.15M | $899.24M | $899.58M | $917.37M | $901.54M | $851.32M | $818.18M | $562.24M | $882.76M | $851.03M | $831.78M | $511.13M | $832.08M | $870.82M | $803.03M | $404.05M | $837.96M | $812.32M | $801.57M | $298.02M | $816.31M | $737.40M | $630.35M | $668.16M | $799.48M | $748.72M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -1.26% | - | 0.24% | 1.30% | 1.08% | 0.78% | 1.04% | 1.76% | 1.20% | 1.05% | 1.03% | 2.11% | 1.58% | 0.74% | 1.16% | 0.70% | 1.00% | 0.83% |
1 analysts predict THC's average Quarter EBITDA for Sep 23 to be $851.03M, with a high of $851.03M and a low of $851.03M. This is 325.51% upper than Tenet Healthcare's previous annual EBITDA (Jun 23) of $200.00M.
Tenet Healthcare Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 16 | 4 | 7 | 1 | - | - | - | - | - | - | - | - | - | - | - | 9 | 9 | 9 | 13 | 13 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $791.00M | - | $293.00M | $296.00M | $274.00M | $268.00M | $179.00M | $279.00M | $420.00M | $449.00M | $258.00M | $222.00M | $414.00M | $-107.00M | $169.00M | $160.00M | $129.00M | $-153.00M |
| Avg Forecast | $314.37M | $284.21M | $267.91M | $312.90M | $316.48M | $261.47M | $247.74M | $292.65M | $280.60M | $226.95M | $186.73M | $147.07M | $157.69M | $117.72M | $122.90M | $133.70M | $120.93M | $451.71M | $66.01M | $105.69M | $149.49M | $101.12M | $105.78M | $59.63M | $93.95M | $31.76M | $-70.26M | $167.40M | $96.91M | $30.97M |
| High Forecast | $314.37M | $284.21M | $267.91M | $312.90M | $316.48M | $261.47M | $247.74M | $292.65M | $280.60M | $257.14M | $247.67M | $176.49M | $175.66M | $117.72M | $122.90M | $160.44M | $120.93M | $542.05M | $66.52M | $126.83M | $150.65M | $101.90M | $106.60M | $71.55M | $94.68M | $32.01M | $-69.53M | $200.88M | $97.66M | $31.21M |
| Low Forecast | $314.37M | $284.21M | $267.91M | $312.90M | $316.48M | $261.47M | $247.74M | $292.65M | $280.60M | $217.21M | $158.23M | $117.66M | $142.72M | $117.72M | $122.90M | $106.96M | $120.93M | $361.37M | $65.33M | $84.56M | $147.95M | $100.08M | $104.69M | $47.70M | $92.98M | $31.44M | $-70.80M | $133.92M | $95.91M | $30.65M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 5.02% | - | 2.38% | 2.21% | 2.27% | 0.59% | 2.71% | 2.64% | 2.81% | 4.44% | 2.44% | 3.72% | 4.41% | -3.37% | -2.41% | 0.96% | 1.33% | -4.94% |
Tenet Healthcare's average Quarter net income forecast for Mar 24 is $147.07M, with a range of $117.66M to $176.49M. THC's average Quarter net income forecast represents a -81.41% decrease compared to the company's last Quarter net income of $791.00M (Dec 23).
Tenet Healthcare SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 16 | 4 | 7 | 1 | - | - | - | - | - | - | - | - | - | - | - | 9 | 9 | 9 | 13 | 13 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $6.83B | - | - | $2.26B | $2.31B | $2.23B | $2.13B | $2.18B | $2.19B | $2.21B | $2.28B | $2.20B | $2.23B | $2.14B | $1.86B | $2.19B | $2.23B | $2.17B |
| Avg Forecast | $2.71B | $2.59B | $2.55B | $2.58B | $2.57B | $2.45B | $2.45B | $2.50B | $2.46B | $2.34B | $2.31B | $2.29B | $2.44B | $2.32B | $2.27B | $2.08B | $2.27B | $2.22B | $2.21B | $1.65B | $2.30B | $2.23B | $2.20B | $1.35B | $2.24B | $2.03B | $1.73B | $3.94B | $2.20B | $2.06B |
| High Forecast | $2.71B | $2.59B | $2.55B | $2.58B | $2.57B | $2.45B | $2.45B | $2.50B | $2.46B | $2.35B | $2.44B | $2.75B | $2.50B | $2.32B | $2.27B | $2.50B | $2.27B | $2.67B | $2.22B | $1.98B | $2.32B | $2.25B | $2.22B | $1.62B | $2.26B | $2.04B | $1.74B | $4.72B | $2.21B | $2.07B |
| Low Forecast | $2.71B | $2.59B | $2.55B | $2.58B | $2.57B | $2.45B | $2.45B | $2.50B | $2.46B | $2.32B | $2.23B | $1.83B | $2.41B | $2.32B | $2.27B | $1.67B | $2.27B | $1.78B | $2.19B | $1.32B | $2.29B | $2.22B | $2.19B | $1.08B | $2.23B | $2.01B | $1.72B | $3.15B | $2.18B | $2.04B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.80% | - | - | 1.08% | 1.02% | 1.00% | 0.96% | 1.32% | 0.95% | 0.99% | 1.03% | 1.63% | 0.99% | 1.06% | 1.08% | 0.56% | 1.01% | 1.06% |
Tenet Healthcare's average Quarter SG&A projection for Mar 24 is $2.29B, based on 4 Wall Street analysts, with a range of $1.83B to $2.75B. The forecast indicates a -66.44% fall compared to THC last annual SG&A of $6.83B (Dec 23).
Tenet Healthcare EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 16 | 4 | 7 | 1 | - | - | - | - | - | - | - | - | - | - | - | 9 | 9 | 9 | 13 | 13 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.01 | - | $2.88 | $2.89 | $2.62 | $2.48 | $1.66 | $2.60 | $3.92 | $4.19 | $2.42 | $2.09 | $3.92 | $-1.02 | $1.61 | $1.53 | $1.24 | $-1.48 |
| Avg Forecast | $3.19 | $2.89 | $2.72 | $3.18 | $3.21 | $2.66 | $2.52 | $2.97 | $2.85 | $2.31 | $1.90 | $1.45 | $1.60 | $1.20 | $1.25 | $1.16 | $1.23 | $1.24 | $0.67 | $1.08 | $1.52 | $1.03 | $1.07 | $0.76 | $0.95 | $0.32 | $-0.71 | $0.29 | $0.98 | $0.31 |
| High Forecast | $3.19 | $2.89 | $2.72 | $3.18 | $3.21 | $2.66 | $2.52 | $2.97 | $2.85 | $2.61 | $2.52 | $1.45 | $1.78 | $1.20 | $1.25 | $1.16 | $1.23 | $1.24 | $0.68 | $1.08 | $1.53 | $1.04 | $1.08 | $0.76 | $0.96 | $0.33 | $-0.71 | $0.29 | $0.99 | $0.32 |
| Low Forecast | $3.19 | $2.89 | $2.72 | $3.18 | $3.21 | $2.66 | $2.52 | $2.97 | $2.85 | $2.21 | $1.61 | $1.45 | $1.45 | $1.20 | $1.25 | $1.16 | $1.23 | $1.24 | $0.66 | $1.06 | $1.50 | $1.02 | $1.06 | $0.75 | $0.94 | $0.32 | $-0.72 | $0.28 | $0.97 | $0.31 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | - | 2.31% | 2.50% | 2.13% | 2.00% | 2.48% | 2.42% | 2.58% | 4.08% | 2.25% | 2.76% | 4.11% | -3.16% | -2.26% | 5.35% | 1.26% | -4.70% |
According to 4 Wall Street analysts, Tenet Healthcare's projected average Quarter EPS for Mar 24 is $1.45, with a low estimate of $1.45 and a high estimate of $1.45. This represents a 18524.10% increase compared to THC previous annual EPS of $0.01 (Dec 23).
Tenet Healthcare Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| AMN | AMN Healthcare Services | $47.14 | $122.33 | 159.50% | Buy |
| SGRY | Surgery Partners | $31.00 | $47.50 | 53.23% | Buy |
| SEM | Select Medical | $35.23 | $40.00 | 13.54% | Buy |
| INNV | InnovAge | $5.99 | $6.80 | 13.52% | Hold |
| ACHC | Acadia Healthcare Company | $78.23 | $84.89 | 8.51% | Buy |
| BKD | Brookdale Senior Living | $6.66 | $7.00 | 5.11% | Buy |
| EHC | Encompass Health | $93.25 | $93.17 | -0.09% | Buy |
| ADUS | Addus HomeCare | $130.13 | $123.00 | -5.48% | Buy |
| UHS | Universal Health Services | $232.56 | $208.47 | -10.36% | Hold |
| PNTG | Pennant Group | $34.52 | $30.67 | -11.15% | Buy |
| THC | Tenet Healthcare | $162.41 | $124.87 | -23.11% | Buy |
| DVA | DaVita | $163.56 | $125.50 | -23.27% | Hold |
| ENSG | Ensign Group | $152.73 | $114.25 | -25.19% | Buy |
| HCA | HCA Healthcare | $394.68 | $291.95 | -26.03% | Buy |
THC Forecast FAQ
Is Tenet Healthcare a good buy?
Yes, according to 11 Wall Street analysts, Tenet Healthcare (THC) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 10 'Buy' recommendations, accounting for 100.00% of THC's total ratings.
What is THC's price target?
Tenet Healthcare (THC) average price target is $124.87 with a range of $47 to $170, implying a -23.11% from its last price of $162.41. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Tenet Healthcare stock go up soon?
According to Wall Street analysts' prediction for THC stock, the company can go down by -23.11% (from the last price of $162.41 to the average price target of $124.87), up by 4.67% based on the highest stock price target, and down by -71.06% based on the lowest stock price target.
Can Tenet Healthcare stock reach $200?
THC's average twelve months analyst stock price target of $124.87 does not support the claim that Tenet Healthcare can reach $200 in the near future.
What are Tenet Healthcare's analysts' financial forecasts?
Tenet Healthcare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $21.6B (high $21.6B, low $21.6B), average EBITDA is $3.66B (high $3.66B, low $3.66B), average net income is $1.12B (high $1.12B, low $1.12B), average SG&A $9.98B (high $9.98B, low $9.98B), and average EPS is $11.36 (high $11.36, low $11.36). THC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $22.56B (high $22.56B, low $22.56B), average EBITDA is $3.82B (high $3.82B, low $3.82B), average net income is $1.18B (high $1.18B, low $1.18B), average SG&A $10.42B (high $10.42B, low $10.42B), and average EPS is $11.98 (high $11.98, low $11.98).
Did the THC's actual financial results beat the analysts' financial forecasts?
Based on Tenet Healthcare's last annual report (Dec 2023), the company's revenue was $20.55B, beating the average analysts forecast of $20.05B by 2.48%. Apple's EBITDA was $974M, missing the average prediction of $3.21B by -69.70%. The company's net income was $1.31B, beating the average estimation of $532.02M by 146.42%. Apple's SG&A was $0, missing the average forecast of $9.11B by -100.00%. Lastly, the company's EPS was $0.0129, missing the average prediction of $5.2 by -99.75%. In terms of the last quarterly report (Dec 2023), Tenet Healthcare's revenue was $5.38B, beating the average analysts' forecast of $5.27B by 2.03%. The company's EBITDA was $-1.127B, missing the average prediction of $892.95M by -226.21%. Tenet Healthcare's net income was $791M, beating the average estimation of $157.69M by 401.61%. The company's SG&A was $6.83B, beating the average forecast of $2.44B by 180.44%. Lastly, the company's EPS was $0.0078, missing the average prediction of $1.6 by -99.51%